全球非鸦片类止痛贴市场规模、份额、趋势和成长分析报告（2026-2034年）

非鸦片类止痛贴市场预计将从 2025 年的 10.7 亿美元成长到 2034 年的 19.1 亿美元，2026 年至 2034 年的复合年增长率为 6.69%。

随着医疗机构和患者寻求更安全的鸦片类止痛药替代方案，全球非鸦片类止痛贴市场正在快速成长。非鸦片类止痛贴片透过皮肤输送药物，缓解局部疼痛，且无鸦片类药物依赖的风险。这些贴片越来越多地用于治疗肌肉疼痛、关节炎和术后不适等疾病。

推动市场成长的关键因素之一是人们对阿片类药物成瘾及其相关健康併发症日益增长的担忧。各国政府和医疗机构正积极推广非鸦片类治疗方法，以减少对传统止痛药的依赖。此外，经皮给药技术的进步也提高了止痛贴片的有效性和便利性。

由于药物配方和贴片技术的不断创新，非阿片类镇痛贴片市场预计未来将持续成长。研究人员正在探索新的活性成分和改进的给药机制，以提供更持久的镇痛效果。随着医疗保健产业不断致力于开发更安全的疼痛管理方案，对非鸦片类镇痛贴片的需求可能会显着增加。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球非鸦片类止痛贴市场：依贴片类型划分

• 市场分析、洞察与预测
• Lidocaine贴剂
• 双氯芬酸钠贴剂
• 水杨酸甲酯贴片
• 辣椒素贴片
• 酮洛芬贴剂
• 其他（草本、薄荷醇等）

第五章 全球非鸦片类止痛贴市场：依通路划分

• 市场分析、洞察与预测
• 零售药房
• 医院药房
• 网路药房
• 其他（超级市场/大卖场、DTC）

第六章 全球非鸦片类止痛贴市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Acorda TherapeuticsInc
  • Teva Pharmaceutical Industries Ltd
  • GSK Plc
  • Endo International Plc
  • Hisamitsu Pharmaceutical Co.Inc
  • IBSA（Institut Biochimique SA）
  • Alkermes Plc
  • Teikoku Seiyaku Co.Ltd
  • Mylan NV

The Non-Opioid Pain Patches Market size is expected to reach USD 1.91 Billion in 2034 from USD 1.07 Billion (2025) growing at a CAGR of 6.69% during 2026-2034.

The Global Non-Opioid Pain Patches Market is growing rapidly as healthcare providers and patients seek safer alternatives to opioid-based pain medications. Non-opioid pain patches deliver medication through the skin to relieve localized pain without the risk of opioid dependency. These patches are increasingly used to manage conditions such as muscle pain, arthritis, and post-surgical discomfort.

One of the major drivers of the market is the rising concern over opioid addiction and related health complications. Governments and healthcare organizations are promoting non-opioid treatment options to reduce reliance on traditional painkillers. In addition, advances in transdermal drug delivery technology have improved the effectiveness and convenience of pain relief patches.

In the future, the non-opioid pain patches market is expected to expand with continued innovation in drug formulations and patch technologies. Researchers are exploring new active ingredients and enhanced delivery mechanisms that provide longer-lasting pain relief. As the healthcare industry continues to focus on safer pain management solutions, the demand for non-opioid pain patches is likely to increase significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Patch Type

• Lidocaine Patches
• Diclofenac Patches
• Methyl Salicylate Patches
• Capsaicin Patches
• Ketoprofen Patches
• Others (Herbal, Menthol, etc.)

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• Others (Supermarkets/Hypermarkets, DTC)

COMPANIES PROFILED

• Acorda Therapeutics, Inc, Teva Pharmaceutical Industries Ltd, GSK plc, Endo International plc, Hisamitsu Pharmaceutical Co, Inc, IBSA Institut Biochimique SA, Alkermes plc, Teikoku Seiyaku Co, Ltd, Mylan NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BY PATCH TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Patch Type
• 4.2. Lidocaine Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Diclofenac Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Methyl Salicylate Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Capsaicin Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Ketoprofen Patches Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others (Herbal, Menthol, etc.) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Distribution Channel
• 5.2. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others (Supermarkets/Hypermarkets, DTC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NON-OPIOID PAIN PATCHES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Patch Type
  • 6.2.2 By Distribution Channel
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Patch Type
  • 6.3.2 By Distribution Channel
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Patch Type
  • 6.4.2 By Distribution Channel
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Patch Type
  • 6.5.2 By Distribution Channel
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Patch Type
  • 6.6.2 By Distribution Channel
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL NON-OPIOID PAIN PATCHES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Acorda TherapeuticsInc
  • 8.2.2 Teva Pharmaceutical Industries Ltd
  • 8.2.3 GSK Plc
  • 8.2.4 Endo International Plc
  • 8.2.5 Hisamitsu Pharmaceutical Co.Inc
  • 8.2.6 IBSA (Institut Biochimique SA)
  • 8.2.7 Alkermes Plc
  • 8.2.8 Teikoku Seiyaku Co.Ltd
  • 8.2.9 Mylan N.V